Trial Profile
Target site pharmacokinetics of ertapenem after multiple doses in diabetes patients with soft tissue infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections; Diabetic complications; Soft tissue infections
- Focus Pharmacokinetics
- 08 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 May 2008 New trial record.